Towa Pharmaceutical Co., Ltd. (4553) has 2 disclosed large-shareholding filings and 0 disclosed disposals on record, filed by 2 distinct investors. Together those filings cover ¥9.6B ($62.0M) in reported transaction value. The earliest filing StockDrifts holds for Towa Pharmaceutical Co., Ltd. is dated 2023-06-06; the most recent is 2026-02-05. Across these filings the average return since disclosure is +77.88%, measured from each filing date to the latest available close.
| Date | Type | Source | Insider | Purpose | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2026-07-06 | BUY | Market Buy | 三井住友DSアセットマネジメント株式会社 Sumitomo Mitsui DS Asset Management Company, Limited | passive | 3.2M | ¥4,180 | -11.2% | ¥2.3B ($15.0M) |
| 2026-02-05 | BUY | Market Buy | 三井住友DSアセットマネジメント株式会社 Sumitomo Mitsui DS Asset Management Company, Limited | passive | 2.7M | ¥3,620 | +2.5% | ¥9.6B ($62.0M) |
| 2023-06-06 | BUY | Market Buy | エルエスブイ・アセット・マネジメント(LSV Asset Management) LSV Asset Management | passive | 1.1M | ¥1,780 | +108.4% | ¥12M ($79K) |
Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Japan insider signal tier research, or browse every Japanese stock we track.